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Warburg  and  his  associates,  Posener and  Negelein  (1924),  have 
shown that within certain limits and with certain exceptions carcino- 
matous tissue has a unique and characteristic metabolism.  They and 
Warburg (1925)  found that normal tissues have a relatively high rate 
of  oxygen  consumption and  a  low  aerobic  glycolysis.  Embryonic 
tissue has high respiration and, under anaerobic conditions, a  high 
glycolysis, but it has only a slight destruction of sugar under aerobic 
conditions.  Neoplastic tissue, on the other hand, has a  rather low 
respiration rate and a high glycolysis under both aerobic and anaerobic 
conditions.  These broad generalizations have been corroborated by 
Murphy and Hawkins (1925),  Rona and Deutsch (1926),  and others. 
The subject is more fully reviewed by Jackson (1929).  Neither gly- 
colysis nor oxygen consumption, however, proved to be an infallible 
guide to the nature of a  given living tissue, so that Warburg (1927) 
resorted  to  a  new value  by  which to  differentiate neoplastic from 
normal tissue.  He points out that when the Pasteur reaction func- 
tions at its maximum, the formation of exactly two molecules of lactic 
acid is suppressed when one molecule of oxygen is consumed, and on 
this basis he suggests a new value "U," which may be regarded as the 
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theoretical aerobic glycolytic rate.  This value U  he finds rather con- 
stantly negative for normal tissue, in the vicinity of zero for embryonic 
tissue, and strongly positive for carcinomata. 
In man  the lymph nodes are subject to various pathological proc- 
esses including what, for lack of a better term, we may call the malig- 
nant lymphomata,  a  classification which is used in this paper to in- 
clude lymphosarcoma, Hodgkin's disease, reticulum cell sarcoma and 
lymphatic leukemia.  Pathologists  are not entirely agreed as  to  the 
nature of these rather varied, but at the same time similar, pathological 
processes.  Some  regard  them  as  neoplasms,  others  as  infectious 
granulomata.  Other  pathologists  again  would  class  some  types  in 
one group, some in the other.  In this paper we are placing Hodgkin's 
disease, as defined below, by itself for comparison with the other types 
of lymphomata. 
As  a  part  of  a  general  investigation  of  this  group  of diseases  it 
occurred to us that a study of the chemical metabolism of pathological 
lymph nodes might  throw some light on  their fundamental  nature. 
The metabolic processes might, we hoped, afford evidence as to whether 
various types of malignant lymphomata were neoplastic or infectious 
in origin.  This paper deals with the  results of the investigation of 
normal and pathological lymph nodes and primary tumors not involv- 
ing lymph nodes, from 71 patients, and is the first of a series of papers 
dealing with various aspects of malignant lymphomata. 
Methods 
As soon as received from surgical operation, the tissue was cut into thin sections, 
averaging 0.3 ram. in thickness,  by a  specially  devised knife consisting  of two 
safety razor blades held parallel,  but slightly apart, in a  suitable metal holder 
provided with adjustments for aligning the blades.  All such sections were imme- 
diately immersed in sterile, normal horse serum, at room temperature, preparatory 
to their transfer to the metabolism chambers.  Sterile cultures of the lymph nodes 
in this horse serum lived as long and as well as in the patient's own serum.  Paraf- 
fine sections were made of all lymph nodes examined. 
The metabolism was carried out in all instances in a modified Thiinburg respira- 
tion apparatus.  Briefly this  consisted  of two small  vials connected one with 
another by means of a long, very fine capillary tube containing a kerosene drop to 
serve as a direct indicator of the oxygen consumption.  The tissue to be metab- 
olized was floated in buffered normal horse serum in an inner chamber.  The moat 
about this inner chamber contained 2 per cent NaOH which served to absorb all H. JACKSON, JR.,  F. PARKER, JR.,  E. C. ~GLOVER  549 
carbon dioxide formed.  The anaerobic glycolysis was determined  in a small vial 
containing horse serum saturated with pure nitrogen which had been passed over 
red hot copper to free it from traces of oxygen.  The serum used in the anaerobic 
experiments  was first  subjected  to a  vacuum to rid it of air and subsequently 
saturated with pure nitrogen.  This anaerobic chamber was attached to the stand 
supporting the Thiinburg apparatus.  The whole apparatus, aerobic and anaerobic 
alike,  was immersed  in a constant temperature water bath at 37.5°C. and kept 
agitated by a suitable  motor.  All apparatus coming in contact with the tissue 
was chemically  clean.  That the possible presence of bacteria did not affect the 
results  was evident from several  specially  devised experiments and also from the 
constancy, from period  to period,  of the tissue metabolism,  as evidenced by the 
oxygen consumption.  Following each experiment  the tissue was washed free of 
serum,  dried at 100°C., and weighed.  From 5  to  25 rag. tissue  was  used.  All 
weights refer to dry tissue. 
Oxygen consumption was read directly on a calibrated  scale attached to the 
capillary.  Readings  were taken every 5 minutes.  The results  are expressed in 
c. ram. per rag. hour.  Glycolysis, or more accurately, sugar destruction  during the 
experimental period was determined by the familiar method of Folin (1929).  The 
figures given in the text are those actually observed, except that in those tumors in 
which there was considerable connective  tissue stroma a suitable  allowance was 
made as this tissue has a metabolism  entirely negligible compared  to that of the 
more active cells composing the rest of the tumor.  The amount of stroma present 
was carefully  estimated  by two independent  observers  from paraffine  sections. 
The observed metabolic  figures were then multiplied  by the appropriate factors. 
In only 14 of the 71  cases was the  amount of stroma increased  sufficiently to 
warrant the application  of a correctional factor. 
Experimental Results 
Normal Nodes.--Four normal nodes were examined.  The average 
aerobic glycolysis  was 0.020 rag., the average anaerobic glycolysis 0.054 
rag., and  the average oxygen consumption 5.7  c.  ram.  In this small 
series  of  cases  there  was  a  marked  uniformity of  the results.  The 
average value U was 4.1, a figure entirely consistent with that found by 
Warburg  for normal lymphoid tissue,  but  slightly higher  than  that 
found in most  normal tissues  elsewhere  in  the  body  which,  as  has 
already been stated,  usually  have  a  negative  U.  These  figures  can 
probably  be  taken  as representative of the normal lymph node, and 
must be used as a  determining value for further correlations. 
Lymphoma.--Under  this heading we here include lymphosarcoma, 
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cell sarcoma, but not Hodgkln's disease.  There were studied meta- 
bolically nodes from 14 such cases.  In contradistinction to the normal 
nodes there was found to be a marked variation in the different factors 
making up the metabolism in these pathological cases.  The average 
aerobic giycolysis was 0.063 mg., over three times that found in the 
normal series.  Three cases had an aerobic glycolysis above 0.083 rag., 
and all of these cases were rapidly fatal, while in two cases  the rate 
fell below 0.035  mg.,  and  these also were highly malignant from a 
clinical point of view.  No correlation, therefore,  could be found between 
degree of malignancy and the rate of aerobic glycolysis.  The nodes 
from case S-29-662 and those from case S-29-1574 gave almost identical 
figures for aerobic glycolysis, yet the former case is alive and well a year 
and a  half later,  while the latter case died in a  few months.  The 
average anaerobic glycolysis was 0.092  mg.  One,  a  case of rapidly 
advancing lymphosarcoma  (S-29-236),  showed  the  extremely high 
figure of 0.206 mg., while another, a case of lymphosarcoma involving 
the stomach (S-29-1585),  had a low figure of 0.047 rag.  Again, no cor- 
relation can be traced.  The oxygen consumption averaged 5.5 c. ram. 
per mg. hour with such extreme variations as 0.7 and '12.6,  yet there 
was no apparent relation between the metabolic rates and either the 
pathological or the clinical findings.  The  value  U  averaged  11.8, 
thus placing these tumors tentatively in  the neoplastic class.  But 
again  extreme  variations  occurred,  as  witness  case  S-29-100  A,  a 
rapidly advancing and rapidly fatal lymphoma with metastases  to 
bone which had a U value of --1.7, and, on the other hand, S-29-236, 
a  lymphosarcoma with a  U  of  4-47  and fatal in approximately the 
same time as the first case.  Again case S-29-662  had a U  value well 
above the general average for this class and well within the limits set 
by Warburg for malignancy, yet the case responded in a  remarkable 
way to high voltage X-ray therapy and has remained well over a period 
of nearly 2 years. 
Hodgkin's Disea~e.--Eighteen cases of  typical Hodgkin's  disease 
were studied.  We class as Hodgkin's disease those nodes which show 
the typical multi-nucleated giant cells described by Dorothy Reed and 
by Sternberg.  The tumor in some of the cases was very cellular, while 
in others it was sclerosed.  The average aerobic glycolysis was 0.052 
mg., slightly lower than the corresponding figure for all other types of 
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about the average within narrow limits, the lowest being 0.030 rag. and 
the highest 0.067  mg.  The  average  oxygen consumption was  5.8 
c. nun.  The anaerobic glycolytic rate was 0.074 mg., again slightly 
lower than that in the other lymphomata.  The  value  U  averaged 
7.3,  slightly  above  the  corresponding value  for  normal nodes but 
definitely below that for tuberculous nodeswhich was 10.3.  From this 
it might be inferred that Hodgkin's disease was infectious in nature, or 
at  least not  neoplastic,  but  it  should  be  remembered  that  the 
lymphosarcoma S-29-100A  had a value U of only --1.7, and another 
lymphosarcoma  infiltrating the stomach and the parotid had a value 
of 3.4.  On the other hand,  a  case of sclerosing Hodgkin's disease 
(S-29-1152),  responding well to X-ray therapy, showed in the node a 
value U  of  19.6,  while another case, histologically similar and clini- 
caUy rapidly fatal  (S-29-1556)  had a low value of 0.9.  So it must be 
recognized that no very clear evidence is obtained as to  the funda- 
mental nature of the lesions from these data. 
Tub~,culosis.--Four  cases of the cellular type of tuberculosis were 
studied.  Necrotic or very fibrous nodes were excluded for obvious 
reasons.  Here it was found that the average aerobic glycolysis was 
0.055  mg., and the average  anaerobic 0.090 rag.  The oxygen  con- 
sumption ran high, averaging 8.2 c. mm., while the U averaged 10.3. 
Nye and Parker (1930) have produced in animals lesions consisting o.f 
closely packed mononuclear cells identical with, or very similar to, 
those found in cellular tuberculosis.  The lesion is particularly promi- 
nent and particularly pure in the lung, and examination of the involved 
lungs from these animals showed that they had an aerobic glycolysis of 
0.05 rag. and anaerobic of 0.09 rag., a U of 15.  The similarity between 
these figures and those of human tuberculosis is  obvious, and the 
figures indicate that the type cell rather than the etiological agent or 
the fundamental nature of the disease is responsible for the character 
of the metabolism.  If one attempts to classify tuberculosis on the 
basis of Warburg's figures one is forced to admit that here again is an 
obvious exception to his general rule; for the observed figures alone 
would indicate rather sharply that the process is neoplastic. 
Carcinoma.--Thirteen  cases of carcinomata involving lymph nodes 
were examined.  Here again, as in the case of Hodgkin's disease, due 
allowance was made, when necessary, for the presence of large amounts 
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glycolysis was 0.088  mg.,  a  figure  far  higher  than  any  other  tissue 
previously examined,  but rates as low as 0.032 rag.  (S-29-1042) were 
found in a slowly growing, highly differentiated epidermoid carcinoma. 
Five cases had  an aerobic glycolysis  above  0.100  rag.,  and  10  were 
above 0.060  rag.  The  average  anaerobic  rate  was  0.142  rag.,  but 
varied  considerably.  With one  exception,  case S-29-1042  again,  all 
were above 0.068 rag.,  and six cases yielded figures which were above 
0.150 mg.  Oxygen consumption was consistently low, averaging 4.1 
c. mm.  As was to be expected from Warburg's work, the value U was 
very  high,  averaging  24,  well  over  twice  that  for  lymphoma  and 
entirely in confirmation of Warburg's findings.  The highest U  value 
was 40.4 in a rapidly growing, highly malignant epidermoid carcinoma 
(S-28-2468).  There  seemed, indeed,  to  be some general correspond- 
ence between the value U and the degree of malignancy.  Thus, S-29- 
1049, S-28-168J, and S-28-2468 all had a U value above 35 and were all 
highly  malignant,  while  S-28-2524  and  S-29-1042  were  relatively 
benign,  slow growing tumors,  and each had a  value below 11.  But 
the  rule  was  by  no  means  invariable.  Roughly  the  same  crude 
parallelism  could  be  traced  between  malignancy  and  anaerobic 
glycolysis, though again there were certain exceptions. 
Sarcoma.--In all, thirteen cases of sarcoma were studied.  In most 
cases the  tumors investigated were primary  loci and  not metastatic 
in lymph nodes.  The metabolism was striking and interesting, in that 
all figures were low.  The average aerobic glycolysis was 0.017 mg., 
with  comparatively  little  variation  except  in  S-29-1803,  where  the 
figure was 0.036 mg.  The average anaerobic glucose destruction was 
0.037  rag.,  again  varying  closely  about  the  mean.  The  U  value 
averaged only 4.9 and the oxygen consumption only 2.4 c. mm.  It is 
be noted that all these figures are far below those of carcinoma.  To be 
sure, S-28-1803 with a  U  of 12.6 comes into the malignant  class, but 
the majority fell far short of it and yet they were all highly malignant 
tumors.  S-29-2965, a melanotic sarcoma, had an anaerobic glycolytic 
rate of but 0.056 mg. with a  U  of but 7.4,  yet it was one of the most 
rapidly growing tumors ever seen in this laboratory.  The conclusion 
is obvious.  Sarcomata do not appear to behave metabolically in the 
same manner as do carcinomata,  and from their relatively low meta- 
bolic  rates  it  is  difficult  to  understand  wherefrom  they  derive  the 
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advance.  If one figures, according to the method of Hawkins (1925) 
the energy requirements of a rapidly growing carcinoma such as S-29- 
1049, one finds that it produces anaerobically 0.093 calories per mg. 
dry weight per hour, aerobically 0.206 calories.  The same calculations 
applied to such an extremely rapidly growing sarcoma as S-29-2965 
show that anaerobically it produces but 0.020 calories and aerobically 
only 0.022  calories.  Again  the  distinction, metabolically  speaking, 
between carcinomata and sarcomata is obvious.  They do not behave 
in  the same manner.  It  should be  noted,  however,  that  even car- 
cinoma itself does not appear in such experiments as these to expend 
much energy in growing.  Aerobically the average energy output of 
these series of carcinomata was 0.033 calories per rag. hour, anaerobi- 
cally 0.054 calories.  The respective averages for sarcomata were 0.018 
and 0.014 and for benign tumors 0.049 and 0.006. 
Benign Tumors.--Three benign tumors were investigated.  As was 
to be expected, their metabolism was low, the aerobic glycolysis being 
0.010  mg.,  and the  anaerobic 0.017  mg.,  and  the U  3.9--figures,  it 
should be noted, not far from those of the highly malignant sarcoma. 
Their oxygen consumption averaged 2.4 c. ram. 
The degree of differentiation of various cells seemed rather definitely 
connected with the degree of difference between the aerobic and anae- 
robic glycolysis. 
For instance, Cases 9,  19,  33, 38, and 40 were tumors (carcinoma, 
lymphoma, etc.) composed of undifferentiated cells, and their percent- 
age difference was only 1 per cent, the highest being 8 per cent.  On 
the contrary, Cases 1, 8, 11, 12, 15, 16, 21, 30, 37, 41, 42, and 78 were 
all tumors composed of well differentiated cells, and the average differ- 
ence was 167 per cent.  Case 12 (S-28-2431) constituted an exception 
in that it was a  highly differentiated tumor (epidermoid carcinoma) 
with a split of only 11 per cent.  No correspondence was found to exist 
between  the  oxygen  consumption  and  the  maturity  of  the  cells, 
though Glover,  Daland  and  Schmitz  (1930)  have found with white 
blood cells of both the myeloid and lymphoid series a definite increase 
of oxygen consumption with increasing maturity.  This they found to 
•  hold true only when the cells were studied in whole blood but not 
when they were suspended in Ringer's solution.  For various reasons 
they  believed  that  whole  blood  gave  more  accurate  information. 
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aerobic and anaerobic glycolysis the greater the degree of cell differ- 
entiation) occurred in almost all the sarcomas, as witness S-29-1913,  a 
highly  differentiated tumor  with  a  split  of  O,  and  S-28-2721,  an 
undifferentiated cell tumor with a split of 127 per cent. 
DISCUSSION 
It was hoped that evidence might be thrown on the question as to 
whether the malignant lymphomata are of infectious or neoplastic 
origin from this study of the aerobic and anaerobic glycolysis and the 
oxygen consumption of 71  lymph nodes and tumors.  Careful com- 
parisons have been made between the microscopic pathology and the 
metabolism.  The various metabolic rates were found to vary over so 
large a  range that few generalizations can be made.  There was,  in 
general, a steady rise in both the aerobic and anaerobic glycolysis from 
the normal nodes through Hodgkin's disease, the lymphoblastomata 
and tuberculous nodes to carcinomata.  The sarcomata and benign 
tumors had very much lower rates.  Their glycoly~is, indeed, is not 
even of the same order of magnitude as  that  of the  carcinomata. 
Much overlapping existed, however, so that from the metabolism alone 
one can not infallibly predict in which class the tissue will fall.  Some 
lymphomata, for instance, had metabolic rates greater than those of 
some cancers.  The oxygen consumpton seemed to bear little or no 
relation to the pathological picture.  It was rather consistently low 
in carcinoma and tended to be high in tuberculosis and some cases of 
Hodgkin's disease.  The value U  was over twice as high in the car- 
cinomata as in any other pathological class, but here again overlapping 
existed to a considerable extent so that a diagnosis of neoplasm could 
not be made on this basis alone.  The U  value for sarcoma was defi- 
nitely low, in no way approaching that of other malignant disease. 
The high metabolic rates found for tuberculous nodes indicated very 
clearly that the type of cell, rather than the nature of the underlying 
process, determined the character of the chemical changes.  This fact 
was further borne out by the figures found for the rabbit lungs filled 
with mononuclears.  Neither speed  of growth nor degree of malig- 
nancy could be predicted from the glycolysis or oxygen consumption." 
The metabolic processes in the sarcomata were of unusual interest. 
The figures of our thirteen cases approached those of benign tumors 
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sarcomata  were  extremely malignant  and  rapidly  growing.  The 
number studied is small and it is quite possible that further investiga- 
tions will show that some human sarcomata have as high  or even 
higher metabolic rates  than  do  carcinomata of  equal  malignancy. 
Such is not our finding at present and further observations on sar- 
comata are in progress. 
Such metabolic rates as are reported here represent the chemical 
activity of the tissue during a relatively brief period of tissue existence. 
They do not necessarily represent the requirements of growth.  One 
of the essential characteristics of neoplastic tissues is their unlimited, 
chaotic and purposeless growth.  To study the chemistry of growth 
rather than that of mere existence one must determine the metabolic 
rates of tissues over a long period of time in tissue cultures.  This is 
being done as a continuance  of the present study. 
CONCLUSIONS 
From a study of the metabolism of 71 lymph nodes and tumors one 
may conclude: 
1.  The nature of a tumor can not be predicted from the metabolism 
because too much overlapping of metabolic rates exists between the 
pathological groups. 
2.  There is no  evidence metabolically one way or another as  to 
whether malignant lymphomata  of any type should  be  classed  as 
neoplastic or as infectious processes. 
3.  The degree of cell differentiation can in most cases be foretold by 
the percentage difference between the aerobic and the anaerobic gly- 
colysis.  The greater the  differentiation the greater the percentage 
difference.  Sarcomata in general constitute an exception to this rule. 
4.  The degree of malignancy in carcinoma, but not in other tumors, 
can, with certain  exceptions, be predicted from the height of the valueU. 
5.  Human sarcomata appear to have a metabolism far more closely 
comparable to  that of  benign  tumors than to  that of carcinomata. 
They do not behave as malignant tumors under the Warburg classi- 
fication.  Their energy requirements are not of the  same order as 
those of carcinoma. 
6.  One can not from the value U or from the glycolytic  rates predict 
whether or not a tissue should be classed as neoplastic. 
7.  Warburg's findings for carcinomata are confirmed  and amplified. 556  LYMPHOID  AND  ~IYELOID  TISSUE  DISEASES.  I 
TABLE  I 
tOxygen]  *Anaero-  con-  ,Per cent  *Aerobic  bic  sump-  "U" 
No.  Path. No.  active  glycolysis 
tissue  glycolysis  __  t/on 
1  28-168J  50  0.116  0.172  3.2  36.6 
2  28-157R  100  0.071  0.117  6.4  16.4 
3  28-158R  100  0.050  0.106  5.2  16.1 
4  28-159R  100  0.051  0.100  5.1  15.0 
5  28-1686  100  0.034  0.037  2.0  4.5 
6  28-1804  100  0.066  0.082  4.4  11.7 
7  28-2093  100  0.041  0.062  4.6  5.8 
8  28-2347  100  0.009  0.014  1.0  2.5 
9  28-2348  100  0.069  0.069  5.0  7.5 
10  28-2370  100  0.024  0.033  0.6  6.5 
11  28-2385  100  0.017  0.028  2.3  2.4 
12  28-2431  50  0.140  0.156  6.4  20.6 
13  28-2454  100  0.006  0.126  9.5  12.2 
14  28-2467  100  0.055  0.082  1.8  17.9 
15  28-2468  60  0.087  0.198  4.5  40.4 
16  28-2475  30  0.114  0.138  2.1  30.3 
17  28-2494  100  0.078  0.100  7.5  10.0 
18  28-2516  100  0.040  0.069  4.4  8.4 
19  28-2524  30  0.096  0.096  8.4  7.2 
20  28-2554  100  0.026  0.044  4.8  1.4 
21  28-2596  100  0.028  0.051  3.7  5.3 
22  28-2611  60  0.054  0.075  7.8  3.1 
23  28~2625  100  0.050  0.090  5.5  11.5 
24  28-2665  100  0.067  0.096  6.4  11.2 
25  28-2703  100  0.049  0.056  5.3  3.6 
26  28-2707  100  0.019  0.040  2.1  5.8 
27  28-2721  100  0.014  0.032  1.4  5.2 
28  28-2758  50  0.070  0.123  7.0  16.8 
29  28-2775  100  0.014  0.024  2.8  0.4 
30  28-2795  100  0.056  0.078  5.1  9.3 
31  28-2917  75  0.076  0.082  3.7  13.6 
32  28-2931  100  0.077  0.106  6.8  11.7 
33  28-3075  100  0.019  0.042  2.4  5.7 
Aerobic-J 
anaero- j  Diagnosis  bic split 
per cent  ~ 
48  Carcinoma 
65  Rabbit  lung  mono, 
nuclears 
110  "  " 
96  "  " 
9  Lymphoma 
24  Hodgkin's 
46  Hodgkin's 
56  Carcinoid 
0  Hodgkin's 
37  Normal node 
65  Arachnoidal fibroblas 
toma 
11  Carcinoma 
31  Tuberculosis 
51  Hodgkin's 
127  Carcinoma 
21  Carcinoma 
28  Hodgkin's 
73  Tuberculosis 
0  Carcinoma 
70  Endothelioma 
82  Normal nodes 
40  Reticulum  cell  sar 
coma 
80  Hodgkin's 
43  Hodgkin's 
16  Hodgkin's 
110  Meningioma 
127  Sarcoma 
61  Carcinoma 
71  Fibrosarcoma 
39  Reticulum  cell  sar, 
coma 
8  Carcinoma 
35  Hodgkin's 
121  Normal node 
* Expressed in mg. per 10 rag. dry weight per hour. 
"~  "  "  c. ram. per rag. dry weight per hour. H.  JACKSON~  JR.~  ~F.  PARKER~  JR.~  E.  C.  GLOVER 
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No,  Path. No. 
34  29-100A 
35  29-236 
36  29-266 
37  29-365 
38  29-399 
39  29-585 
40  29-628 
41  29-639 
42  29-640 
43  29-662 
44  29-1027 
45  29-1042 
46  29-1049 
47  29-1152 
48  29-1279 
49  29-1556 
50  29-1574 
51  29-1585 
52  29-1754 
53  29-1778 
54  29-1802 
55  27-1803 
56  29-1834 
57  29-1913 
58  29-2066 
59  29-2309 
60  29-2368 
61  29-2636 
62  29-2651 
63  29-J-1 
64  29-J-2 
65  29-2866 
66  29-2965 
67  30-396 
68  30-600 
69  30-682 
70  30-768 
71  29-664 
I 
Per cent *Aerobic,  *Anacro- 
active  bic  tissue  glycolysis'  glycolysis 
100  0.090 
100  0.083 
20  0.115 
100  0.059 
100  0.044 
I00  0.022 
100  0.001 
100  0.010 
100  0.030 
100  0.077 
100  0.019 
75  0.032 
50  0.150 
100  0.047 
I00  0.100 
100  0.025 
100  0,071 
100  0.047 
100  0.068 
100  0.059 
I00  0,047 
100  0.036 
100  0.043 
100  0.016 
33  0.042 
20  0.050 
100  0.032 
100  0.041 
100  0.046 
100  0.014 
100  0.010 
100  0.030 
100  0.024 
100  0.018 
100  0.062 
100  0,011 
I00  0.061 
50  0.012 
0,093 
0.206 
0.'115 
0.075 
0,045 
0,095 
0.012 
0.090 
0.054 
0.136 
0.074 
0. O48 
0.250 
0.100 
0.100 
0.031 
0.071 
0.047 
O. 079 
i  0.105 
!0.057 
1o.o77 
0.068 
0.016 
0.168 
0.200 
0.067 
0.054 
0.065 
0.024 
0.015 
0.060 
0.056 
0.060 
i 0.120 
0.027 
0.108 
0.046 
tOxygen  Aerobic- 
con-  .U~  ans.ero*  sump-  bic split  Diagnosis 
tion  per cent 
12.5  --1.7  3  Lymphoma 
1.8  47.9  149  Lymphoma 
4,5  17.8  0  Carcinoma 
2.5  13.8  27  Lymphoma 
0.7  9.8  2  Lymphoma 
1.6  20,5  330  Lymphoma 
4.4  -8.5  1000  Glioma 
11.8  -1.1  800  Normal node 
4.7  4.1  64  Hodgkin's 
8.6  16.8  77  Lymphoma 
4.0  10.5  290  Tuberculosis 
2.0  10.0  50  Carcinoma 
29.5  35.5  67  Carcinoma 
2.7  19.6  112  Hodgkin's 
6,4  12.2  0  Lymphoma 
3.4  0.9  32  Hodgkin's 
6.4  4.9  0  Lymphoma 
4.8  3.4  0  Lymphoma 
9.7  0.3  14  Hodgkin's 
2.3  20.9  78  Carcinoma 
4.3  5.6  21  Hodgkin's 
3.3  12.6  114  Fibrosarcoma 
8.9  --0.9  58  Hodgkin's 
1.2  2.9  0  Fibrosarcoma 
3.9  34.2  300  Carcinoma 
I0.0  30.0  300  Carcinoma 
5.3  6.1  110  Hodgkin's 
4.9  1.6  32  Hodgkin's 
6,5  3.3  41  i Hodgkin's 
1.9  2.2  41  ~ Osteogenic sarcoma 
0.8  2.1  50  ;  Sarcoma 
2.3  10.4  1001  Fibrosarcoma 
I 
3.3  7.4  133  I Melanotic sarcoma 
3.9  7.2  232  I Myxofibrosarcoma 
10.4  9.2  94  Lymphoma 
1.2  4.3  60  Fibrosarcoma 
12.6  30.0  77[  Lymphoma 
9.6  --7.7  281  Melanoticsarcoma m 
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